MICROCHIP TECHNOLOGY INCORPORATED

MCHP

CIK 0000827054 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1.19B
↑+15.6% +$160Mvs FY2024 (Q4)
Operating Income
$152M
↑+390.9% +$121Mvs FY2024 (Q4)
Net Income
$63M
Gross Profit
$707M
↑+25.9% +$146Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
39/100
  • Profitability
    0ROIC 1.2% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.59 (above 1.5 = solid)
  • Leverage
    60D/E 0.80 (under 0.5 = conservative)
  • Efficiency
    6Asset Turnover 0.28x (1.0+ = capital-efficient)
  • Growth
    69Revenue YoY +15.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 12.8% · trend -5.2pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project MCHP's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -32.2%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$20.06
Total enterprise IV
$10.78B
Diluted shares
0.54B
Terminal PV
$7.60B (70% of total)
Year-5 FCF
$895M
YearProjected FCFDiscounted PV
+1$795M$723M
+2$819M$677M
+3$844M$634M
+4$869M$594M
+5$895M$556M
Terminal$12.23B$7.60B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$91M
investment in PP&E
Dividends paid (TTM)
$737M
cash returned to holders
Stock buybacks (TTM)
$0
share count reduction
Stock-based comp (TTM)
$228M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$14.33B
everything owned
Stockholders' equity
$6.56B
shareholder claim
Net debt
$5.12B
LT debt minus cash

Recent performance · 72 quarters

Revenue↑+15.6% +$160M
$1.19B
Net Income↑+217.0% +$116M
$63M
Free Cash Flow↑+25.8% +$66M
$319M
Operating Margin↑+9.8pts
12.8%

Drill down